Overview
Galle Face Capital Partners is a listed investment company whose portfolio includes Sri Lankan banking, consumer, hospitality, healthcare and tobacco shares. Its reported income is therefore driven more by investment income and portfolio valuations than by conventional operating sales.
The central current change is a confirmed rights issue intended to reduce short-term borrowings while adding capital for future investments. It also expands the ordinary share base, making future per-share outcomes dependent on both the deployment of the proceeds and portfolio performance.
Price performance
At LKR 21.10 on 10 November 2026, WAPO had risen 29.1% over one month against a 9.2% ASPI gain, but remained down 19.7% over one year while the ASPI fell 3.0%. The share was 34.3% of the way from its 52-week low to high, so the recent rebound had not restored the earlier peak.
Returns are restated for the March 1:4 split and the confirmed 1:1 rights issue due to go ex-rights on 23 November, rather than representing the unadjusted screen-price record alone. The three-year record shows five falls of 15% or more, with the deepest at 55% and not yet recovered, illustrating a history of substantial drawdowns.
Median daily turnover was LKR 0.4 million over 60 sessions. A LKR 1 million order is more than everything that trades on a typical day, 264% of it, so building or exiting that size represents a large part of normal trading activity.
Valuation
At 2.9 times P/E, the market is paying LKR 2.90 for every LKR 1 of trailing profit, the lowest reading among the 48 sector peers with usable P/E data. The 0.89 times P/B means the price is below the stated net assets per share, or about 89 cents for each rupee of net assets; this sits at the 38th percentile of 53 banks and finance-sector peers. Annual ROE was 30.6%, which helps reconcile a low P/B with a profitable portfolio rather than treating the discount to book as an isolated warning.
The 3.2% dividend yield is close to the sector median, while dividends per share rose from LKR 0.451 in FY2024 to LKR 0.677 in FY2026. The payout used 9.3% of trailing earnings, leaving considerable earnings retention, although investment-company profits are not necessarily recurring cash income.
Against its own record, WAPO is cheaper than 58% of days since January 2019 on P/B. A comparable own-history P/E record is unavailable. The latest quarter supplied 12.9% of trailing EPS; at its year-ago net margin on the same revenue, the present P/E would be 1.7 times rather than 2.9 times, showing that trailing earnings contain stronger earlier portfolio gains.
News and sentiment
Direct coverage was normal rather than unusually loud: one article in the past 30 days versus a monthly baseline of 1.3. Across 90 days, nine material articles comprised three positive and six neutral items, with no negative articles recorded.
The main disclosures concerned the rights issue. The company filed the proposal on 2 October and rights dates on 6 November; the confirmed terms are one new share for each existing share at LKR 16, with an ex-date of 23 November. A LKR 0.70 scrip dividend for FY2025/26 was also reported, while the earlier LKR 0.30 cash dividend had already gone ex-dividend on 22 September 2025.
Financials
June-quarter revenue rose 76.2% year-on-year to LKR 74.6 million, yet operating profit fell 70.7% to LKR 88.0 million and net profit fell 72.2% to LKR 83.5 million. This is the key tension in the filing: more reported revenue did not translate into stronger portfolio profit, and the fall in net profit closely followed the lower operating result rather than a large below-the-line charge.
Gross margin is not applicable from the reported data for this investment company. Operating margin was 118.1% versus 709.2% a year earlier, while net margin was 112.0% versus 710.1%; profits exceed the revenue line because investment income and gains are material to the business model. June net margin ranked a middling 4th of eight comparable June quarters, and operating margin ranked 5th of eight, so the weaker year-on-year result was not an extreme within its own June record.
For the twelve months to June 2026, revenue fell 39.8% and ROE was 21.9%, underscoring that the earnings base is portfolio-value sensitive rather than a stable revenue stream. The March split increased ordinary shares from 29.6 million to 118.3 million without changing stated capital, so per-share comparisons across the split need that mechanical share-count change kept in view.
Risks
The principal risk is portfolio-income volatility. June net profit was LKR 217.0 million lower than the comparable quarter, despite revenue growth, and the company holds listed equities across several Sri Lankan sectors. The profit behind the current P/E therefore rests on movements in investment income and valuations that can be materially different between quarters.
The upcoming rights issue is the other material risk and opportunity. It will add one new share for every existing share, so each pre-rights share represents a smaller proportion of the enlarged company; whether that is offset depends on the value created by debt repayment and deployment into investments. The issue price is below the 10 November closing price, but the data does not establish the eventual value of the assets acquired or retained with the proceeds.
Balance-sheet leverage was comparatively contained at the last audited year-end, with liabilities equal to 0.09 times equity versus 0.12 times a year earlier. However, the stated use of rights proceeds for short-term bank and intercompany borrowings indicates that funding structure remains important. The wider banks and finance backdrop also included higher policy rates and inflation as at 10 November, conditions that can affect valuations and financing costs across the portfolio environment.
Outlook
As at 10 November 2026, the September interim filing was due, with the usual reporting window running from 3 to 14 November. It is the next evidence on whether the June profit slowdown persisted or whether portfolio income recovered, and it will supersede the June-based financial measures in this analysis.
The confirmed 23 November rights ex-date is the other immediate company event. It will formally enlarge the share base and deliver the capital earmarked for borrowings and investments; the available data cannot determine how effectively those proceeds will be deployed or what future portfolio returns they will earn.